Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Clinical Clinical Trial

Official title:
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Status Recruiting

Clinical Trial Summary

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Artificial Intelligence Algorithms
Clinical
Development of the Virtual Biopsy
Glioma
Radiological
Tumor Grade

Clinical Trial Details

NCT number	NCT04313140
Study type	Interventional
Source	Poitiers University Hospital
Contact	Rémy GUILLEVIN, Pr
Phone	05.49.44.45.42
Email	remy.guillevin@chu-poitiers.fr
Status	Recruiting
Phase	N/A
Start date	February 22, 2021
Completion date	June 2026

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01694108` - Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.	Phase 4
	Not yet recruiting	`NCT04584424` - Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia